Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New feature:   Introducing the Finviz Matrix

Learn More
Market News Market Pulse Stocks News ETF News Crypto News

NovaBridge Biosciences

Contributing Author

Recent Articles by NovaBridge Biosciences

Sep-08
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director NBP GlobeNewswire
Aug-27
NovaBridge Biosciences to Participate in September Investor Conferences NBP GlobeNewswire
Aug-20
NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution NBP GlobeNewswire
Aug-13
NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026 NBP GlobeNewswire
Jul-24
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026 NBP GlobeNewswire
Jun-29
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer NBP +20.73% GlobeNewswire
Jun-16
NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer NBP GlobeNewswire
May-28
NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference NBP GlobeNewswire
May-12
NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference NBP GlobeNewswire
Apr-22
NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value NBP GlobeNewswire
Apr-07
NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update NBP GlobeNewswire
Mar-16
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer NBP GlobeNewswire
Mar-09
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study NBP GlobeNewswire
Mar-03
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026 NBP -7.25% GlobeNewswire
Mar-02
NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference NBP +5.18% GlobeNewswire
Feb-19
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform NBP GlobeNewswire
Feb-17
NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer NBP GlobeNewswire
Jan-20
NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei NBP +5.09% GlobeNewswire
Jan-06
NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in Patients with 1L Metastatic Gastric Cancer NBP -11.21% GlobeNewswire
Dec-30
NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026 NBP GlobeNewswire
Dec-10
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO NBP GlobeNewswire
Dec-03
NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO NBP GlobeNewswire
Nov-20
NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward NBP GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)